Global Microphysiological System Supply, Demand and Key Producers, 2026-2032
Description
The global Microphysiological System market size is expected to reach $ 427 million by 2032, rising at a market growth of 15.8% CAGR during the forecast period (2026-2032).
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
The global key companies of Microphysiological System include Emulate, Mimetas, InSphero, TissUse, CN Bio, Valo Health (TARA Biosystems), Hesperos, TNO, 28bio, Newcells Biotech, etc. In 2024, the global five largest players hold a share approximately 48.81% in terms of revenue.
Due to better policy and financial support in European countries and USA and earlier research, the overall industry of microphysiological system has developed rapidly, and the industrialization process in other regions such as Asia is lagging behind.
It is worth noting that because the microphysiological system industry is still in the early stages of development, and the mid-stream and downstream demand has not yet increased, many microphysiological system companies play an upstream role to some extent and mostly conduct organoid and organ-on-chip research on their own. Research and development of chip automation, high-throughput operating instruments and imaging equipment.
With the further development of the industry in the future and the implementation of relevant policies and standards, the industry's demand for upstream will increase, which will promote the birth of more professional upstream companies and the business transformation of some microphysiological system companies.
This report studies the global Microphysiological System demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Microphysiological System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Microphysiological System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Microphysiological System total market, 2021-2032, (USD Million)
Global Microphysiological System total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Microphysiological System total market, key domestic companies, and share, (USD Million)
Global Microphysiological System revenue by player, revenue and market share 2021-2026, (USD Million)
Global Microphysiological System total market by Type, CAGR, 2021-2032, (USD Million)
Global Microphysiological System total market by End User, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Microphysiological System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emulate, Mimetas, TissUse, InSphero, Hesperos, CN Bio, TNO, 28bio, Beijing Daxiang Biotech, Newcells Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Microphysiological System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by End User. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Microphysiological System Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Microphysiological System Market, Segmentation by Type:
Human Organ and Tissue Models
Disease Models
Non-Human Species Models
Global Microphysiological System Market, Segmentation by End User:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
Companies Profiled:
Emulate
Mimetas
TissUse
InSphero
Hesperos
CN Bio
TNO
28bio
Beijing Daxiang Biotech
Newcells Biotech
Nortis (Quris-Al)
Valo Health (TARA Biosystems)
Altis Biosystems
Draper Laboratory
Netri
Bi/ond
ImmuONE
AlveoliX
Cherry Biotech
Ananda Devices
Obatala Sciences
BiomimX
React4life
Aracari Bio
StemPharm
SynVivo
Key Questions Answered
1. How big is the global Microphysiological System market?
2. What is the demand of the global Microphysiological System market?
3. What is the year over year growth of the global Microphysiological System market?
4. What is the total value of the global Microphysiological System market?
5. Who are the Major Players in the global Microphysiological System market?
6. What are the growth factors driving the market demand?
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
The global key companies of Microphysiological System include Emulate, Mimetas, InSphero, TissUse, CN Bio, Valo Health (TARA Biosystems), Hesperos, TNO, 28bio, Newcells Biotech, etc. In 2024, the global five largest players hold a share approximately 48.81% in terms of revenue.
Due to better policy and financial support in European countries and USA and earlier research, the overall industry of microphysiological system has developed rapidly, and the industrialization process in other regions such as Asia is lagging behind.
It is worth noting that because the microphysiological system industry is still in the early stages of development, and the mid-stream and downstream demand has not yet increased, many microphysiological system companies play an upstream role to some extent and mostly conduct organoid and organ-on-chip research on their own. Research and development of chip automation, high-throughput operating instruments and imaging equipment.
With the further development of the industry in the future and the implementation of relevant policies and standards, the industry's demand for upstream will increase, which will promote the birth of more professional upstream companies and the business transformation of some microphysiological system companies.
This report studies the global Microphysiological System demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Microphysiological System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Microphysiological System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Microphysiological System total market, 2021-2032, (USD Million)
Global Microphysiological System total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Microphysiological System total market, key domestic companies, and share, (USD Million)
Global Microphysiological System revenue by player, revenue and market share 2021-2026, (USD Million)
Global Microphysiological System total market by Type, CAGR, 2021-2032, (USD Million)
Global Microphysiological System total market by End User, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Microphysiological System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emulate, Mimetas, TissUse, InSphero, Hesperos, CN Bio, TNO, 28bio, Beijing Daxiang Biotech, Newcells Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Microphysiological System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by End User. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Microphysiological System Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Microphysiological System Market, Segmentation by Type:
Human Organ and Tissue Models
Disease Models
Non-Human Species Models
Global Microphysiological System Market, Segmentation by End User:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
Companies Profiled:
Emulate
Mimetas
TissUse
InSphero
Hesperos
CN Bio
TNO
28bio
Beijing Daxiang Biotech
Newcells Biotech
Nortis (Quris-Al)
Valo Health (TARA Biosystems)
Altis Biosystems
Draper Laboratory
Netri
Bi/ond
ImmuONE
AlveoliX
Cherry Biotech
Ananda Devices
Obatala Sciences
BiomimX
React4life
Aracari Bio
StemPharm
SynVivo
Key Questions Answered
1. How big is the global Microphysiological System market?
2. What is the demand of the global Microphysiological System market?
3. What is the year over year growth of the global Microphysiological System market?
4. What is the total value of the global Microphysiological System market?
5. Who are the Major Players in the global Microphysiological System market?
6. What are the growth factors driving the market demand?
Table of Contents
174 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Microphysiological System Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by End User
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
